About

App Release Information

Version: 3.8
Date: 2020/10/19


Terms of Use

MD Anderson makes no warranties or representations, express or implied, with respect to any of the content, including as to the present accuracy, completeness, timeliness, adequacy, or usefulness of any of the content, and MD Anderson will not be liable for any loss or damages arising from your use of or reliance on information contained in this site or other sites that may be linked to from our site. You may view the content contained on DrBioRight solely for your own personal, non-commercial purposes. You may not copy, transfer, reproduce, modify, or create derivative works of any part of the DrBioRight content for any reason, and you may not use the DrBioRight content for any commercial purpose (e.g., you may not distribute, license, or sell the content, alone, or in combination with other materials, to any other person, or entity) without the express written permission of MD Anderson. For commercial licensing inquiries, please contact us at DrRight_Info@mdanderson.org.


External Resources

• Genomic Data Commons Data Portal (GDC)
• Cancer Cell Line Encyclopedia (CCLE)
• Catalogue of Somatic Mutations in Cancer (COSMIC)
• Genomics of Drug Sensitivity in Cancer (GDSC)
• Cancer Therapeutics Response Portal (CTRP)
• CTD2: Cancer Target Discovery And Development (CTD2)
• NIH Library of Integrated Network-Based Cellular Signatures (LINCS)
• cBioPortal (cBio)


Publication

• Next-Generation Analytics for Omics Data
Jun Li, Hu Chen, Yumeng Wang, Mei-Ju May Chen, and Han Liang. Cancer Cell (2020) doi: 10.1016/j.ccell.2020.09.002